529 related articles for article (PubMed ID: 27495267)
1. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.
McAleese KE; Walker L; Erskine D; Thomas AJ; McKeith IG; Attems J
Brain Pathol; 2017 Jul; 27(4):472-479. PubMed ID: 27495267
[TBL] [Abstract][Full Text] [Related]
2. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
Arai T; Mackenzie IR; Hasegawa M; Nonoka T; Niizato K; Tsuchiya K; Iritani S; Onaya M; Akiyama H
Acta Neuropathol; 2009 Feb; 117(2):125-36. PubMed ID: 19139911
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
[TBL] [Abstract][Full Text] [Related]
8. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
9. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
10. Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.
Iseki E
Neuropathology; 2004 Mar; 24(1):72-8. PubMed ID: 15068176
[TBL] [Abstract][Full Text] [Related]
11. The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis.
Gurnani AS; Gavett BE
Neuropsychol Rev; 2017 Mar; 27(1):1-17. PubMed ID: 27878426
[TBL] [Abstract][Full Text] [Related]
12. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
Lemstra AW; de Beer MH; Teunissen CE; Schreuder C; Scheltens P; van der Flier WM; Sikkes SA
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):113-118. PubMed ID: 27794030
[TBL] [Abstract][Full Text] [Related]
13. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
Walker L; Simpson H; Thomas AJ; Attems J
Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
[TBL] [Abstract][Full Text] [Related]
15. Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology.
van der Zande JJ; Steenwijk MD; Ten Kate M; Wattjes MP; Scheltens P; Lemstra AW
Neurobiol Aging; 2018 Nov; 71():171-178. PubMed ID: 30149288
[TBL] [Abstract][Full Text] [Related]
16. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
17. Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
Sadiq D; Whitfield T; Lee L; Stevens T; Costafreda S; Walker Z
J Alzheimers Dis; 2017; 58(2):463-470. PubMed ID: 28453473
[TBL] [Abstract][Full Text] [Related]
18. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia.
Thomas AJ; Mahin-Babaei F; Saidi M; Lett D; Taylor JP; Walker L; Attems J
Alzheimers Res Ther; 2018 Mar; 10(1):27. PubMed ID: 29490691
[TBL] [Abstract][Full Text] [Related]
19. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.
Nedelska Z; Ferman TJ; Boeve BF; Przybelski SA; Lesnick TG; Murray ME; Gunter JL; Senjem ML; Vemuri P; Smith GE; Geda YE; Graff-Radford J; Knopman DS; Petersen RC; Parisi JE; Dickson DW; Jack CR; Kantarci K
Neurobiol Aging; 2015 Jan; 36(1):452-61. PubMed ID: 25128280
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
